Exclusive: A solution for measuring edoxaban!
Stago is pleased to announce our latest innovative products: STA®-Edoxaban Calibrator and STA®-Edoxaban Control. In combination with STA®-Liquid Anti-Xa, they allow the measurement of Edoxaban plasma concentration.
Read more
Diagnostica Stago Announces Canadian Launch of its Second Max Generation Analyzer, the STA R Max®
July 4, 2016, Toronto, ON Canada – Stago Canada, Ltd./Ltée. announced the launch of the STA-R Max® Haemostasis analyser, the newest member of the Max Generation family of Haemostasis analysers.
Read more
Diagnostica Stago Launches New Procoagulant
January 2014, Parsippany, NJ, USA – Diagnostica Stago, Inc. introduces Megamix-Plus SSC (cat # 01078) and Megamix-Plus FSC (cat # 01077), for detection of procoagulant microparticles on both side-scatter and forward-scatter flow cytometers. Microparticles are tissue factor-bearing phospholipid vesicles that are a source of procoagulant phospholipids. Microparticle levels have been studied in several pathologies including cancer, diabetes, sickle cell disorder, and parasitic and viral infections.
Read more
Clarity Peer Group Program for Stago Customers
Clarity for Stago customers is a fully web based peer group program. Today’s fast paced and hectic diagnostic world demands a product that can quickly identify shifts, trends, and allow for immediate corrective action. Clarity provides all of this and more.
Read more
Stago Launches Ready to Use Heparin Anti-Xa Assay
August 01, 2011, Parsippany, NJ, USA – The STA® - Liquid Anti-Xa assay (catalog #s 00311US and 00322US) from Diagnostica Stago provides a new, easier to use tool for unfractionated as well as low molecular weight heparin monitoring applications. It is a ready to use, liquid format improvement on the popular STA®-Rotachrom® Heparin assay currently available (catalog #s 00612 and 00661). The liquid feature has the benefit for the customer of a more ergonomic work flow as well as preventing reconstitution errors.
Read more